Aplus Biotechnology Corporation Limited (TPEX:6918)
Taiwan
· Delayed Price · Currency is TWD 107.50
+0.50 (0.47%)
Apr 24, 2025, 1:03 PM CST
TPEX:6918 Market Cap
TPEX:6918 has a market cap or net worth of 3.25 billion as of April 24, 2025. Its market cap has increased by 113.43% in one year.
Market Cap
3.25B
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
107.50
Market Cap Chart
Since January 6, 2023, TPEX:6918's market cap has increased from 1.52B to 3.25B, an increase of 113.00%. That is a compound annual growth rate of 38.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2025 | 3.25B | 32.79% |
| Dec 31, 2024 | 2.44B | 77.04% |
| Dec 29, 2023 | 1.38B | -9.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 160.86B |
| Caliway Biopharmaceuticals | 93.54B |
| Bora Pharmaceuticals Co., LTD. | 69.42B |
| Lotus Pharmaceutical | 56.52B |
| Polaris Group | 29.08B |
| Oneness Biotech | 27.68B |
| Pegavision | 25.55B |
| Lumosa Therapeutics | 25.50B |